Status:
COMPLETED
Remimazolam and Propofol Anesthesia in Elderly Patients
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Hemodynamics
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Remimazolam is a recently developed ultra-short agonist acting at the benzodiazepine binding site of the gamma-aminobutyric acid (GABA)A receptor. Remimazolam has a combination of the hemodynamic stab...
Eligibility Criteria
Inclusion
- ASA I, II patients over 65 years old undergoing general anesthesia
Exclusion
- cardiac surgery
- neurosurgery
- liver surgery
- uncontrolled hypertension
- bronchial asthma
- body mass index ≥ 30 kg/m2
- severe heart, liver, kidney disease
Key Trial Info
Start Date :
February 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2023
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT05201300
Start Date
February 2 2022
End Date
January 18 2023
Last Update
July 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea, 16499